Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Schmid

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Assay and Drug Development Technologies|May 5, 2007
Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assayJ Fraser Glickman, Andres Schmid
Assay and Drug Development Technologies|July 3, 2008
Scintillation proximity assays in high-throughput screeningJ Fraser Glickman, Andres Schmid, Sandrine Ferrand
Assay and Drug Development Technologies|September 27, 2005
Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptorSandrine Ferrand, Andres Schmid, Caroline Engeloch, et al.
Journal of Biomolecular Screening|May 20, 2011
Screening for mevalonate biosynthetic pathway inhibitors using sensitized bacterial strainsSandrine Ferrand, Jianshi Tao, Xiaoyu Shen, et al.
Scientific Reports|October 21, 2017
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitorsShin Numao, Franziska Hasler, Claire Laguerre, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Assay and Drug Development Technologies|May 5, 2007
Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assayJ Fraser Glickman, Andres Schmid
Assay and Drug Development Technologies|July 3, 2008
Scintillation proximity assays in high-throughput screeningJ Fraser Glickman, Andres Schmid, Sandrine Ferrand
Assay and Drug Development Technologies|September 27, 2005
Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptorSandrine Ferrand, Andres Schmid, Caroline Engeloch, et al.
Journal of Biomolecular Screening|May 20, 2011
Screening for mevalonate biosynthetic pathway inhibitors using sensitized bacterial strainsSandrine Ferrand, Jianshi Tao, Xiaoyu Shen, et al.
Scientific Reports|October 21, 2017
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitorsShin Numao, Franziska Hasler, Claire Laguerre, et al.
Pageof 1